Compare CZFS & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZFS | HLN |
|---|---|---|
| Founded | 1984 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.6M | 41.7B |
| IPO Year | N/A | N/A |
| Metric | CZFS | HLN |
|---|---|---|
| Price | $58.72 | $10.12 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.2K | ★ 10.4M |
| Earning Date | 01-29-2026 | 07-31-2025 |
| Dividend Yield | ★ 3.41% | 1.80% |
| EPS Growth | 24.64 | ★ 41.64 |
| EPS | ★ 7.10 | 0.23 |
| Revenue | $107,399,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | N/A | $1.51 |
| Revenue Next Year | $5.45 | $4.67 |
| P/E Ratio | ★ $8.26 | $21.47 |
| Revenue Growth | ★ 9.73 | N/A |
| 52 Week Low | $49.96 | $8.71 |
| 52 Week High | $66.06 | $11.42 |
| Indicator | CZFS | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 66.08 |
| Support Level | $60.78 | $9.82 |
| Resistance Level | $61.61 | $9.65 |
| Average True Range (ATR) | 2.05 | 0.13 |
| MACD | -0.25 | 0.05 |
| Stochastic Oscillator | 41.93 | 94.41 |
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.